PHOTOTHERAPY systems
Foot Phototherapy- NEW!
Dermawand - wound care
Related products
TRU-BLU acne treatment - NEW!
Replacement Lamps/Bulbs 
Measuring Devices  
Eye Protection
PRESCRIBING PHOTOTHERAPY
Phototherapy vs Biologics
PUVA - UVA plus Psoralen
NB UVB vs PUVA vitiligo study
Blue Lights for Acne
Blue Light Studies Prove Value
Scalp Psoriasis Treatment 
Narrowband UVB phototherapy
PHYSICIAN DISCOUNTS
SUPPORTING YOUR PATIENTS
Medicare Reimbursement
Insurer Coverage and Payouts
Letter of Medical Necessity
PHOTOTHERAPy in practice
Adding Phototherapy to Practice
Pediatric Dermatology
Psoriasis Patients Underserved
Phototherapy for Podiatry
Small Units for Small Patches
Patient HOME UNITS
Full Body Folding Unit  
Handheld Spot Treatment 
Home UVB Light Panels
Efficacy of Home Phototherapy
Cost of At-Home Phototherapy
NEWS
NYT: Psoriasis drugs hit ceiling
Biologics cost more than house
State of phototherapy training
Upcoming Trade Shows
ABOUT NATIONAL BIOLOGICAL
Hear From Our Customers
On-site Manufacturing Facility
Current Research and Links
About Us
NEED HELP?
Site Map
Contact Us
800-338-5045

 


PATIENTS     PHYSICIANS     THIRD PARTY PAYERS     HOME    
save on dermawanddermawand order or contact form

INSURANCE COVERAGE FOR BIOLOGICS AND PHOTOTHERAPY FOR SEVERE PSORIASIS

Poster presented at American Academy of Dermatology 56th annual convention, Feb 2-6, 2007  Christopher B. Yelverton, MD, MBA1; Greg Simpson, MD1; Steven R. Feldman, MD, PhD1-3 Departments of Dermatology1, Pathology2, and Public Health Sciences3, Wake Forest University Health Sciences, Winston Salem, NC  <read full poster>

INTRODUCTION: Insurance companies vary widely in their coverage policies for severe psoriasis therapies and the range of treatment options may fall under multiple portions of a patient’s health benefits package (medical, pharmacy, durable medical equipment) with some options not being covered at all.  These variations in coverage options may be a significant hindrance to the selection of an ideal treatment plan than other well-studied, less-expensive options.

METHODS:  We reviewed insurance policy bulletins, statements of coverage/medical necessity, and prior authorization forms for three large insurance carriers regarding psoriasis treatment with biologic agents and phototherapy. Specific attention was placed on body surface area requirements and need for prior treatment failures.

Discussion: We looked at 3 large insurance carriers’ (Aetna, Cigna, and BCBS of California) coverage for biologics and phototherapy. While it may seem intuitive that disease coverage of larger body surface areas would be warranted for phototherapy, as it treats large areas, such requirements may be detrimental to both patients and insurers. Given that there are several phototherapy devices specifically designed for smaller area treatments, and that phototherapy is significantly less costly than biologics, these policies are neither medically nor financially viable. Likewise, requirement for demonstrated efficacy of office-based phototherapy prior to prescription may take several sessions. Given that a single month’s supply of a typical biologic exceeds the cost of a standard home phototherapy unit, this restriction is not justified.  <read full poster>

Learn more about our unique contracting opportunities
Contact us

 

 
 
 

 



Clinical UVA/UVB PhototherapyFoldalite-32 - Houva II - Houva III - Hand/Foot II - TRU-BLU
Phototherapy for home use: Panosol II -- Dermalight80 - Foldalite III - Handisol - Hand/Foot II